Pharmaceuticals - Community Register


Community list of not active medicinal products for human use


Product information

Invented name: HumaSPECT
Auth. number : EU/1/98/083
Active substance : votumumab
ATC: Anatomical main group: V - Various
Therapeutic subgroup: V09 - Diagnostic radiopharmaceuticals
Pharmacological subgroup: V09I - Tumour detection
Chemical subgroup: V09IA - Technetium (99mTc) compounds
Chemical substance: V09IA01 - technetium (99mTc) antiCarcinoEmbryonicAntigen antibody
(See WHO ATC Index)
Indication: Patients with histologically proven carcinoma of the colon or rectum for imaging of recurrence and/or metastases
Marketing Authorisation Holder: KS Biomedix Llmited
1 Occam Court, Surrey Research Park, Guildford, Surrey GU2 7HJ, United Kingdom
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/1998 Centralised - Authorisation EMEA/H/C/145 (1998)2818 of 25/09/1998
11/05/2001 Centralised - Variation (no change in Commission Decision) EMEA/H/C/145/I/1
09/11/2001 Centralised - Transfer Marketing Authorisation Holder EMEA/H/C/145/T/2 (2001)3510 of 07/11/2001
17/07/2002 Centralised - Transfer Marketing Authorisation Holder EMEA/H/C/145/T/3 (2002)2790 of 15/07/2002
25/09/2003 Centralised - Withdrawal (not renewed)